Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Atossa Genetics Inc (NASDAQ:ATOS)

0.22
Delayed Data
As of Feb 10
 -0.01 / -4.35%
Today’s Change
0.14
Today|||52-Week Range
2.65
-31.25%
Year-to-Date
No recent news for Atossa Genetics Inc.

Today’s Trading

Previous close0.23
Today’s open0.23
Day’s range0.22 - 0.24
Volume132,769
Average volume (3 months)217,800
Market cap$7.0M
Dividend yield--
Data as of 02/10/2016

Growth & Valuation

Earnings growth (last year)+12.86%
Earnings growth (this year)+18.03%
Earnings growth (next 5 years)--
Revenue growth (last year)-16.85%
P/E ratioNM
Price/Sales65.36
Price/Book0.59

Competitors

 Today’s
change
Today’s
% change
NUINNutrastar Internatio...-0.05-11.39%
TPITianyin Pharmaceutic...-0.01-4.55%
BVXVBiondVax Pharmaceuti...+0.19+5.59%
XTLBX T L Biopharmaceuti...+0.03+2.34%
Data as of 2:10pm ET, 02/10/2016

Financials

Next reporting dateMarch 24, 2016
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$526.0K
Annual profit (last year)-$14.7M
Net profit margin-2,786.92%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Steven C. Quay
Chief Operating Officer
Scott Youmans
Corporate headquarters
Seattle, Washington

Forecasts

Partner Offers